1-3 of 3
Louis Kayitalire
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Phase 1 First-in-Human Study of FS118, a Tetravalent Bispecific Antibody Targeting LAG-3 and PD-L1 in Patients with Advanced Cancer and PD-L1 Resistance

Free
Timothy A. Yap, Patricia M. LoRusso, Deborah J. Wong, Siwen Hu-Lieskovan, Kyriakos P. Papadopoulos, Josefin-Beate Holz, Urszula Grabowska, Cristian Gradinaru, Kin-Mei Leung, Sylwia Marshall, Claire S. Reader, Roslin Russell, Richard C.A. Sainson, Claire J. Seal, Christopher J. Shepherd, Fiona Germaschewski, Daniel Gliddon, Omer Stern, Lesley Young, Neil Brewis, Louis Kayitalire, Michelle Morrow
Journal: Clinical Cancer Research
Clin Cancer Res (2023) 29 (5): 888–898.
https://doi.org/10.1158/1078-0432.CCR-22-1449
Published: 01 March 2023
View articletitled, A Phase 1 First-in-Human Study of FS118, a Tetravalent Bispecific Antibody Targeting LAG-3 and PD-L1 in Patients with Advanced Cancer and PD-L1 Resistance
Open the PDF for A Phase 1 First-in-Human Study of FS118, a Tetravalent Bispecific Antibody Targeting LAG-3 and PD-L1 in Patients with Advanced Cancer and PD-L1 Resistance in another window
Includes: Supplementary data
Journal Articles

A Phase I Safety and Pharmacologic Study of a Twice Weekly Dosing Regimen of the Oral Taxane BMS-275183

Free
Linda E. Bröker, Stephan A. Veltkamp, Elisabeth I. Heath, Bart C. Kuenen, Helen Gall, Ludovic Astier, Susan Parker, Louis Kayitalire, Patricia M. Lorusso, Jan H.M. Schellens, Giuseppe Giaccone
Journal: Clinical Cancer Research
Clin Cancer Res (2007) 13 (13): 3906–3912.
https://doi.org/10.1158/1078-0432.CCR-06-2875
Published: 02 July 2007
View articletitled, A Phase I Safety and Pharmacologic Study of a Twice Weekly Dosing Regimen of the Oral Taxane BMS-275183
Open the PDF for A Phase I Safety and Pharmacologic Study of a Twice Weekly Dosing Regimen of the Oral Taxane BMS-275183 in another window
Journal Articles

Pemetrexed Combined with Oxaliplatin or Carboplatin as First-Line Treatment in Advanced Non–Small Cell Lung Cancer: A Multicenter, Randomized, Phase II Trial

Free
Giorgio V. Scagliotti, Cornelius Kortsik, Graham G. Dark, Allan Price, Christian Manegold, Rafael Rosell, Mary O'Brien, Patrick M. Peterson, Daniel Castellano, Giovanni Selvaggi, Silvia Novello, Johannes Blatter, Louis Kayitalire, Lucio Crino, Luis Paz-Ares
Journal: Clinical Cancer Research
Clin Cancer Res (2005) 11 (2): 690–696.
https://doi.org/10.1158/1078-0432.690.11.2
Published: 08 February 2005
View articletitled, Pemetrexed Combined with Oxaliplatin or Carboplatin as First-Line Treatment in Advanced Non–Small Cell Lung Cancer: A Multicenter, Randomized, Phase II Trial
Open the PDF for Pemetrexed Combined with Oxaliplatin or Carboplatin as First-Line Treatment in Advanced Non–Small Cell Lung Cancer: A Multicenter, Randomized, Phase II Trial in another window